Abstract
The signal transducer and activator of transcription (STAT) proteins and their mechanisms of signaling were originally discovered in the context of normal interferon signaling, where they have been shown to have specific roles in mediating host defenses. It is now known that many cytokines, hormones and growth factors utilize STAT signaling pathways to control a remarkable variety of biological responses, including development, differentiation, cell proliferation, and survival. Given the critical roles of STAT proteins in these fundamental cellular processes, which are often altered in cancer, there is accumulating evidence defining a critical role for STAT proteins in oncogenesis. Members of this relatively small family of proteins serve as both transducers of cytoplasmic signals and nuclear transcription factors, thereby directly converting a stimulus at the cell surface to an alteration in the genetic program. Moreover, STAT proteins can cross-talk with other central signaling pathways, such as the mitogen-activated protein kinase (MAPK) family of proteins and the nuclear receptor signaling pathways. On the othe r hand, other proteins are known to interact with and modulate STAT signaling pathways, including histone acetyl-transferases and the protein inhibitor of activated STAT (PIAS) family of protein. The present review will try to address some questions concerning the increasingly complex biological functions of STAT proteins, the many diverse mechanisms of STAT regulation and the expanding number of target genes that mediate the biological responses elicited by STAT signaling pathways.
Current Genomics
Title: STAT Signaling and Cell Function
Volume: 3 Issue: 5
Author(s): Fernando de Miguel and Allen C. Gao
Affiliation:
Abstract: The signal transducer and activator of transcription (STAT) proteins and their mechanisms of signaling were originally discovered in the context of normal interferon signaling, where they have been shown to have specific roles in mediating host defenses. It is now known that many cytokines, hormones and growth factors utilize STAT signaling pathways to control a remarkable variety of biological responses, including development, differentiation, cell proliferation, and survival. Given the critical roles of STAT proteins in these fundamental cellular processes, which are often altered in cancer, there is accumulating evidence defining a critical role for STAT proteins in oncogenesis. Members of this relatively small family of proteins serve as both transducers of cytoplasmic signals and nuclear transcription factors, thereby directly converting a stimulus at the cell surface to an alteration in the genetic program. Moreover, STAT proteins can cross-talk with other central signaling pathways, such as the mitogen-activated protein kinase (MAPK) family of proteins and the nuclear receptor signaling pathways. On the othe r hand, other proteins are known to interact with and modulate STAT signaling pathways, including histone acetyl-transferases and the protein inhibitor of activated STAT (PIAS) family of protein. The present review will try to address some questions concerning the increasingly complex biological functions of STAT proteins, the many diverse mechanisms of STAT regulation and the expanding number of target genes that mediate the biological responses elicited by STAT signaling pathways.
Export Options
About this article
Cite this article as:
Miguel de Fernando and Gao C. Allen, STAT Signaling and Cell Function, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350318
DOI https://dx.doi.org/10.2174/1389202023350318 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
Current Molecular Medicine Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry CASC15: A Tumor-Associated Long Non-Coding RNA
Current Pharmaceutical Design Molecularly Targeted Therapy in Breast Cancer: The New Generation
Recent Patents on Anti-Cancer Drug Discovery Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Melanoma
Current Cancer Therapy Reviews Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Current Gene Therapy Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders
Current Drug Metabolism Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied
Recent Patents on Anti-Cancer Drug Discovery Nanoemulsion: A Novel Eon in Cancer Chemotherapy
Mini-Reviews in Medicinal Chemistry PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Current Drug Targets Association Between miR-146a rs2910164 Polymorphism and Breast Cancer Susceptibility: An Updated Meta-Analysis of 9545 Cases and 10030 Controls
MicroRNA p16<sup>INK4</sup> as a Biomarker in Oropharyngeal Squamous Cell Carcinoma
Recent Patents on Biomarkers Microwave-assisted Synthesis of Novel Triazolyl Pyrazolyl Pyrazoline Substituted Coumarins and Their Antimicrobial Activity
Current Microwave Chemistry Stem Cell Differentiation Stage Factors and their Role in Triggering Symmetry Breaking Processes during Cancer Development: A Quantum Field Theory Model for Reprogramming Cancer Cells to Healthy Phenotypes
Current Medicinal Chemistry PRAME/EZH2-Mediated Regulation of TRAIL: A New Target for Cancer Therapy
Current Molecular Medicine Discovery of BRM Targeted Therapies: Novel Reactivation of an Anticancer Gene
Letters in Drug Design & Discovery Role of TGF- β in the Tumor Stroma
Current Cancer Drug Targets Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy
Current Angiogenesis (Discontinued)